Allergic rhinitis Board decisions

The Board granted service connection for an acquired psychiatric disorder, to include major depressive disorder with psychotic features and insomnia disorder, as secondary to the Veteran's service-connected tinnitus but denied increased ratings for rhinitis and chronic sphenoid sinusitis and service connection for obstructive sleep apnea.

The Board granted service connection for tinnitus and a nasal disability, including allergic rhinitis and sinusitis. An increased rating of 70 percent was granted for PTSD with insomnia.

The Board denied the Veteran's claims for a compensable rating for his right little finger fracture and allergic rhinitis, finding that the evidence did not support higher ratings under applicable criteria.

The veteran withdrew his appeal, stating that he was rated at 100 percent and there are no remaining claims for appellate consideration.

The Board granted service connection for mild facial acne, allergic rhinitis, and depression based on new and relevant evidence. The claims for gastroesophageal reflux disease (GERD), residuals of a right eye injury, and an acquired psychiatric disorder were denied.

The Board remands the issues for further development, including obtaining relevant records and scheduling examinations.

The Board granted new and relevant evidence to readjudicate the claim of service connection for allergic rhinitis, but remanded the matter for further action.

The Board granted an effective date of August 10, 2022, for service connection for chronic sinusitis and allergic rhinitis under the PACT Act.

The Board denied the Veteran's claim for a clothing allowance in calendar year 2021 for triamcinolone 0.023% topical cream due to insufficient evidence showing that the medication causes irreparable damage to his clothing.

The Board denied service connection for obstructive sleep apnea, allergic rhinitis, chronic sinusitis, fibromyalgia, a stomach disability (upper and lower), and chronic fatigue syndrome as the evidence did not support the presence of these conditions during or approximate to the pendency of the claim.

The Board denied service connection for kidney disease, fatty liver disease, maxillary sinusitis, and allergic rhinitis. The claim for an immune disorder was remanded.

The Board denied service connection for sinusitis and rhinitis as the Veteran does not have a diagnosis or recurring symptoms of these conditions.

The Board granted an effective date of July 30, 2022 for the award of a 50 percent rating for generalized anxiety disorder and major depressive disorder (psychiatric disorder) but denied earlier effective dates for other conditions.

The Board granted service connection for right knee disability, including strain and osteoarthritis, but denied an evaluation in excess of 10 percent disabling for allergic rhinitis.

The Board remands the issue of a compensable disability rating for the Veteran's service-connected allergic rhinitis due to an inadequate VA examination.

The Board reinstated a separate rating of 10 percent for the Veteran's perforated nasal septum with chronic epistaxis and granted a separate 10 percent rating for vertigo/lightheadedness associated with it, while denying a higher rating for the perforated nasal septum and a separate rating for difficulty breathing.

The Board denied the Veteran's claim for service connection for sinusitis due to a lack of evidence supporting a current diagnosis. The claim for rhinitis was remanded for further medical evaluation.

The Board granted service connection for rhinitis, sinusitis, and obstructive sleep apnea (secondary to now service-connected rhinitis) based on the evidence of record.

The Board granted service connection for allergic rhinitis, effective August 5, 2021.

The Board denied service connection for TBI, RLE radicular pain, sinusitis, and an increased rating for PTSD. The claims for service connection for DM II, ED, headaches, left thumb disability and scar, right thumb, increased ratings for rhinitis, IBS with GERD, and OSA with bronchitis were remanded.